[Photo] Researchers Sweating It Out in COVID-19 Treatment Research

Countries around the world are racing to develop vaccines and treatments to overcome the novel coronavirus infection (COVID-19). The domestic bio venture company, Engicam Life Sciences, has received approval for a new drug substance from the U.S. Food and Drug Administration (FDA) and is conducting Phase 2 clinical trials. Ahead of the New Year 2021, researchers at Engicam Life Sciences' central research institute in Jecheon, Chungbuk, are working hard on the COVID-19 treatment EC-18./Jecheon=Reporter Kang Jinhyung aymsdream@

This content was produced with the assistance of AI translation services.